While we did not observe efficacy from either single agent, anti-PD-L1 plus anti-TGF-β significantly reduced tumor size relative to PBS or anti-TGF-β alone (p < 0.03; Fig. 1e, f). This evidence concerns the gene TGFB1 and neoplasm.